PLEGRIDY — Total Revenue
Biogen PLEGRIDY — Total Revenue increased by 1.7% to $64.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $59.50M to $64.30M. Over 3 years (FY 2022 to FY 2025), PLEGRIDY — Total Revenue shows a downward trend with a -9.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market adoption or successful pricing strategies, while a decrease may signal increased competition, patent expirations, or a shift in patient preference toward newer therapies.
Detailed definition
This metric represents the total gross revenue generated from the sale of a specific pharmaceutical product within the c...
Peer comparison
Comparable to product-specific revenue lines reported by other biopharmaceutical companies, often analyzed alongside market share data and therapeutic area growth rates.
biib_segment_plegridy_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $89.50M | $86.20M | $80.00M | $91.50M | $80.90M | $79.50M | $73.20M | $82.10M | $65.50M | $73.90M | $65.10M | $68.10M | $61.30M | $66.00M | $59.50M | $69.00M | $58.40M | $63.20M | $64.30M |
| QoQ Change | — | -3.7% | -7.2% | +14.4% | -11.6% | -1.7% | -7.9% | +12.2% | -20.2% | +12.8% | -11.9% | +4.6% | -10.0% | +7.7% | -9.8% | +16.0% | -15.4% | +8.2% | +1.7% |
| YoY Change | — | — | — | +2.2% | -6.1% | — | -8.5% | -10.3% | -19.0% | -7.0% | -11.1% | -17.1% | -6.4% | -10.7% | -8.6% | +1.3% | -4.7% | -4.2% | +8.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's plegridy — total revenue?
- Biogen (BIIB) reported plegridy — total revenue of $64.30M in Q1 2026.
- How has Biogen's plegridy — total revenue changed year-over-year?
- Biogen's plegridy — total revenue increased by 8.1% year-over-year, from $59.50M to $64.30M.
- What is the long-term trend for Biogen's plegridy — total revenue?
- Over 3 years (2022 to 2025), Biogen's plegridy — total revenue has grown at a -9.0% compound annual growth rate (CAGR), from $331.90M to $250.10M.
- What does plegridy — total revenue mean?
- The total sales revenue generated by a specific pharmaceutical product.